Endo International plc

306 articles about Endo International plc

• Endo International Announces Appointment Of Craig Paterson, M.D. As Chief Medical Officer

  9/8/2015

• Endo International Announces U.S. District Court Ruling Upholding OPANA ER Intellectual Property

  8/17/2015

• Endo International Announces Appearance At Canaccord Genuity 35th Annual Growth Conference

  8/12/2015

• Endo International Reports Second Quarter 2015 Financial Results

  8/10/2015

• Endo International Divests Non-Core Business Lines From Litha Healthcare Group International Business, Enhancing Focus On Specialty Pharmaceuticals

  8/5/2015

• Endo International To Announce Second Quarter 2015 Financial Results On August 10, 2015

  7/27/2015

• Endo International Announces Pricing Of Private Offering Of Senior Notes

  6/24/2015

• Endo International Closes Offering Of 27,627,628 Ordinary Shares

  6/11/2015

• Endo International Prices Offering Of 24,024,025 Ordinary Shares

  6/5/2015

• Endo International Announces Proposed Public Offering Of $1.75 Billion Of Ordinary Shares

  6/3/2015

• Endo International Release: First Ever Peyronie's Disease (PD) Treatment Guidelines Support Use Of XIAFLEX In Appropriate Patients

  5/19/2015

• Endo International Announces Updated XIAFLEX Label With Recurrence And Retreatment Data In Patients With Dupuytren's Contracture

  5/18/2015

• Endo International Employees Participate In 2nd Annual "Endo Gives" Day Of Volunteering, Serving The Communities Where They Live And Work

  5/14/2015

• Endo International Reports First Quarter 2015 Financial Results

  5/11/2015

• Endo International Announces Appearance At UBS Global Healthcare Conference

  5/6/2015

• Endo International Announces Appointment Of Matthew J. Maletta As Chief Legal Officer

  4/28/2015

• Endo International To Announce First Quarter 2015 Financial Results On May 11, 2015

  4/27/2015

• Valeant Sweetens Salix Deal to $173 Per Share After Teaming Up With Ackman and Endo International Withdraws

  3/16/2015

• Employees at Three Major Biopharmas Remain Uncertain, As Salix Confirms Bid From Endo International

  3/13/2015

• Valeant Comments On Endo International Offer To Acquire Salix

  3/12/2015